HOT NEWS
Merck total revenues increase 3.2% to € 2.6 billion » The Merck Group's first-quarter 2012 total revenues rose 3.2% to € 2,645 million compared to €...
Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication i... » Abbott (NYSE: ABT) today announced that the XIENCE PRIME™ and the XIENCE V® Everolimus Eluting Co...
GSK statement on BBC Panorama broadcast: 'the truth about tax' » GSK issued the following statement in response to the BBC Panorama programme related to Corporation ...
Novartis drug Signifor® approved in the EU as the first medication to treat pat... » Novartis announced that the European Commission has approved Signifor® (pasireotide) for the treatm...
Amgen to acquire Mustafa Nevzat, a leading privately held Turkish pharmaceutical... » Amgen (NASDAQ:AMGN), the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (...
FORXIGA (dapagliflozin) receives positive CHMP opinion » AstraZeneca and Bristol-Myers Squibb Company today announced that the Committee for Medicinal Produc...
Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative Co... » Abbott today announced that the European Commission has approved HUMIRA® (adalimumab) for the treat...
Novartis QVA149 Phase III COPD studies meet primary endpoints » The first three Novartis QVA149 Phase III studies in the treatment of chronic obstructive pulmonary ...
BYETTA® approved for use with basal insulin in Europe » Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the...
GSK reinforces commitment to youth training » GSK announced the launch of a new multi-disciplinary apprenticeship scheme. The programme, which wil...
Sanofi
SanofiSanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For further information, please visit www.sanofi.com.

Sanofi RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Sanofi and the Institut Pasteur create four prestigious awards 2240
2 Sanofi fourth-quarter and full-year net sales 1519
3 Genzyme Announces European Approval of Framingham Manufacturing Plant 1507
4 Sanofi net sales up 10.1% and Business net income up 4.1% at CER 1571
5 Findings from Two-Year Pivotal Phase III TEMSO Trial 1945
6 Lixisenatide Significantly Reduces HbA1c Without Increasing Hypoglycemia in Patients Uncontrolled on Sulfonylureas 4251
7 Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation 4146
8 Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute 4544
9 Sanofi Pasteur and International Vaccine Institute Partner against Dengue 5371
10 Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right 5694
11 European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis 5161
12 Sanofi-aventis Establishes Research Collaboration with Harvard University 6829
13 Sanofi-aventis Initiates 10,000 Patient Study with Multaq® in Permanent Atrial Fibrillation 7269
14 Sanofi-aventis and CureDM Sign Exclusive Worldwide License Agreement on Novel Regenerative Compound to Treat Diabetes 6461
15 AgaMatrix and sanofi-aventis Enter Global Diabetes Partnership 6968
16 Sanofi Pasteur's A(H1N1) Vaccine HUMENZA®* Recommended by European Medicines Agency 4998
17 My child matters Supports Seven New Childhood Cancer Care Projects 4235
18 Multaq® Approved in the European Union for patients with atrial fibrillation 4608
19 Panenza® and Humenza® Influenza A(H1N1) Vaccines Demonstrate Robust Immune Response After One Dose 6679
20 Multaq® (dronedarone) Recommended for Approval in the European Union 4447
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share

Banner